Member Profile

View All Members
Dr. Rhonda Bohn
ScD, MPH

(Pharmaco)-Epidemiologist with over 25 years of experience in the health care environment including clinical drug research, drug safety, health outcomes, database studies and other observational research. Owner and principal of Bohn Epidemiology, LLC (www.bohnepidemiology.com).

Thorough understanding of epidemiology, health economics and outcomes research, and risk management. Global experience with study design, protocol development, study implementation and report/manuscript writing.

 

Key Publications

Bohn RL, Cooney M, Deodhar A, et al. Incidence and prevalence of axial spondyloarthritis: methodologic challenges and gaps in the literature. Clin Exp Rheumatol 2018 Mar-Apr;36(2):263-274.

 

    Gagne JJ, Rassen JA, Choudry NK, Bohn RL, Patrick AR, Sridhar G, Daniel GW, Liu J, Schneeweiss S. Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrel. Drug Saf 2014;37(3):151-161.

 

    Patorno E, Glynn RJ, Hernandez-Diaz S, Avorn J, Wahl PM, Bohn RL, Mines D, Liu J, Schneeweiss S. Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings. J Am Heart Assoc 2013;2(4):e000208.

 

    Velentgas P, Amato AA, Bohn RL, Chan KA, Cochrane T, Funch DP, Dashevsky I, Duddy AL, Gladowski P, Greenberg SA, Kramer JM, McMahill-Walraven C, Nakasato C, Spettell CM, Syat BL, Wahl PM, Walker AM, Zhang F, Brown JS, Platt R. Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination. Pharmacoepidemiol Drug Saf 2012;21(12):1350-1358.

 

    Bykov K, Bohn R, Ewenstein BM, et al. Use of Bypassing Agents and Risk of Thromboembolic Events in Patients with Haemophilia and Inhibitors. Thromb Haemost 2017;117(12): 2267-2273.

Current Positions/Chairs:

  • Owner and Principal Epidemiologist
    Bohn Epidemiology
  • Member
    IPSG Access Expert Working Group

Key Institutions

  • Bohn Epidemiology
    LLC
    Boston, MA USA

Research Interests

  • Pharmacoepidemiology
  • Drug Safety
  • Evidence-Based Medicine
  • Health Outcomes
  • Therapeutic areas of interest include rare disease, coagulation disorders, neurodegenerative disorders, neuromuscular diseases, mental health including dementia and Alzheimer’s disease

Achievements

  • Received her MPH from Yale University and ScD in Epidemiology from Harvard University.
  • Serves on Advisory Boards and Steering Committees for large-scale and multi-database studies representing clients and Medical Society Organizations
  • Authored over 50 articles published in peer-reviewed journals and is a reviewer for many journals including Pharmacoepidemiology and Drug Safety, the Journal of Managed Care Pharmacy, Drug Safety, Thrombosis and Haemostasis, Pediatrics, and Haemophilia.
  • Served on the Editorial Board for Pharmacoepidemiology and Drug Safety from 2017-2018 and is an active member and Fellow of the International Society for Pharmacoepidemiology (ISPE) and served on its Board from 2014–2016.